Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

NCT03253913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lymphangioleiomyomatosis

Interventions

DRUG: Sirolimus
DRUG: Resveratrol

Sponsor

University of Cincinnati

Collaborators

[object Object]